ABEO vs JNJ · rev $20.1M vs P/E 17, rev $49.37B
Abeona Therapeutics Inc (ABEO) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
ABEO currently screens at market cap $301.8M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the ABEO and JNJ stock pages for the full models.
Not investment advice.